KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Adaptive Biotechnologies (ADPT) Current Leases: 2020-2024

Historic Current Leases for Adaptive Biotechnologies (ADPT) over the last 5 years, with Dec 2024 value amounting to $10.2 million.

  • Adaptive Biotechnologies' Current Leases fell 5.78% to $9.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was $9.4 million, marking a year-over-year decrease of 5.78%. This contributed to the annual value of $10.2 million for FY2024, which is 9.11% up from last year.
  • According to the latest figures from FY2024, Adaptive Biotechnologies' Current Leases is $10.2 million, which was up 9.11% from $9.4 million recorded in FY2023.
  • Adaptive Biotechnologies' Current Leases' 5-year high stood at $10.2 million during FY2024, with a 5-year trough of $3.5 million in FY2020.
  • For the 3-year period, Adaptive Biotechnologies' Current Leases averaged around $9.6 million, with its median value being $9.4 million (2023).
  • Data for Adaptive Biotechnologies' Current Leases shows a peak YoY skyrocketed of 82.59% (in 2022) over the last 5 years.
  • Over the past 5 years, Adaptive Biotechnologies' Current Leases (Yearly) stood at $3.5 million in 2020, then skyrocketed by 43.24% to $5.1 million in 2021, then skyrocketed by 82.59% to $9.2 million in 2022, then rose by 1.67% to $9.4 million in 2023, then rose by 9.11% to $10.2 million in 2024.